project id: TCGA-HNSC; case submitter id: TCGA-CQ-A4CG; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.75; rna integrity number: 9.4; age at index: 78; days to birth: -28637; days to death: 430; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1933; age at diagnosis: 28637; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 391.0; icd 10 code: C06.0; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cheek mucosa; synchronous malignancy: No; tissue or organ of origin: Cheek mucosa; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Yes; cigarettes per day: 3.835616438356164; pack years smoked: 70.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-CQ-A4CG-01A-11; percent lymphocyte infiltration: 6.0; percent monocyte infiltration: 1.0; percent necrosis: 8.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 42.0; percent tumor nuclei: 80.0;